Inge‐Marie Obdeijn

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false‐negative mammography

Madeleine A Tilanus-Linthorst, Leon C. Verhoog, Inge‐Marie Obdeijn et al. · International Journal of Cancer · 2002 · 194 citations

Medicine, Oncology, Pathology +17

<i>BRCA1</i>-Associated Breast Cancers Present Differently From <i>BRCA2</i>-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study

Adriana J. Rijnsburger, Inge‐Marie Obdeijn, R. Kaas et al. · Journal of Clinical Oncology · 2010 · 181 citations · Full text

Medicine, Genetics, Oncology +17

Survival benefit in women with <i>BRCA1</i> mutation or familial risk in the <scp>MRI</scp> screening study (<scp>MRISC</scp>)

Sepideh Saadatmand, Inge‐Marie Obdeijn, Emiel J. Rutgers et al. · International Journal of Cancer · 2015 · 97 citations · Full text

Medicine, Oncology, Preventive Medicine +17

MR Imaging-Guided Sonography Followed by Fine-Needle Aspiration Cytology in Occult Carcinoma of the Breast

Inge‐Marie Obdeijn, Elise M. J. Brouwers-Kuyper, Madeleine M.A. Tilanus‐Linthorst et al. · American Journal of Roentgenology · 2000 · 74 citations · Full text

Medicine, Oncology, Radiology +17

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition

Inge‐Marie Obdeijn, Claudette E. Loo, Adriana J. Rijnsburger et al. · Breast Cancer Research and Treatment · 2009 · 70 citations · Full text

Medicine, Oncology, Radiology +14